BONN, Germany--(BUSINESS WIRE)-- #COVID19--DiosCURE Therapeutics SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action...
FREDERICK, Md.--(BUSINESS WIRE)--Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs,...
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative.
Source Read More
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four...
INGELHEIM, Germany & OXFORD, England & LONDON--(BUSINESS WIRE)--Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic collaboration and licensing...
